Nicox S.A. has entered into a significant licensing agreement with Kowa Company, Ltd., granting Kowa...

The U.S. Food and Drug Administration (FDA) has accepted for review Aldeyra Therapeutics’ resubmitte...

Harrow has announced a definitive commercialization agreement with Samsung Bioepis, granting Harrow ...

Krystal Biotech has announced the dosing of the first patient in its EMERALD-1 phase 1/2 clinical tr...

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to SAR446597, a one-t...

KALA Bio has announced the completion of enrollment in its CHASE (Corneal Healing After SEcretome th...

Nanoscope Therapeutics has announced the initiation of a rolling submission of a biologics license a...

AAVantgarde Bio has announced that the US Food and Drug Administration (FDA) has cleared its investi...

Belite Bio, Inc. has announced the completion of enrollment in its pivotal phase 3 PHOENIX trial, a ...

LENZ Therapeutics and Laboratoires Théa have announced a license and commercialization agreement und...